← Leaderboards
David E Schiff
University Of Pittsburgh At Pittsburgh
$250,106
Attributed
$250,106
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$250,106 · 3
By mechanism
U01$247,072 · 1
M01$3,034 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jeremy N Rich$24,023,429
- Constantinos George Hadjipanayis$4,552,869
- Ian F. Pollack$10,728,894
- Susan Manzi$6,430,165
- Surinder Kumar Batra$34,830,369
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchGliomaNeoplasm /Cancer ChemotherapyHuman Therapy EvaluationClinical Trial Phase INeoplasm /Cancer Relapse /RecurrenceCarmustineAntineoplasticsAlkyltransferaseDosageDrug Screening /EvaluationEnzyme ActivityEnzyme InhibitorsGuanine AnalogIrinotecanComputed Axial TomographyTissue Resource /RegistryMagnetic Resonance ImagingClinical TrialsNeoplasm /Cancer PharmacologyBrain NeoplasmsPaclitaxelPharmacokinetics
Grant awards (10)
PRE SURGICAL O6 BENZYLGUANINE TREATMENT OF PTS W/ MALIGNANT GLIOMA$0
M01 · FY2002 · RR
IRINOTECAN IN RECURRENT MALIGNANT GLIOMA$0
M01 · FY2002 · RR
IRINOTECAN IN RECURRENT MALIGNANT GLIOMA$0
M01 · FY2002 · RR
PRE SURGICAL O6 BENZYLGUANINE TREATMENT OF PTS W/ MALIGNANT GLIOMA$0
M01 · FY2002 · RR
NABTC MEMBER INSTITUTION GRANT (UCSF PROJECT LEADER)$126,348
U01 · FY2001 · CA
IRINOTECAN IN RECURRENT MALIGNANT GLIOMA$0
M01 · FY2001 · RR
PRE SURGICAL O6 BENZYLGUANINE TREATMENT OF PTS W/ MALIGNANT GLIOMA$0
M01 · FY2001 · RR
NABTC MEMBER INSTITUTION GRANT (UCSF PROJECT LEADER)$120,724
U01 · FY2000 · CA
PRE SURGICAL O6 BENZYLGUANINE TREATMENT OF PTS W/ MALIGNANT GLIOMA$3,034
M01 · FY2000 · RR
IRINOTECAN IN RECURRENT MALIGNANT GLIOMA$0
M01 · FY2000 · RR